David Meek, Founder of FerGene

David Meek is the founder of FerGene. FerGene has raised $570M in total funding. Backed by Ferring Pharmaceuticals, Blackstone Life Sciences.

About David Meek

David Meek transitioned from Ipsen to become the CEO of FerGene, a gene therapy spinout launched by Ferring Pharmaceuticals and Blackstone Life Sciences. He is leading the company's efforts to develop and commercialize nadofaragene firadenovec, a gene therapy for bladder cancer.

David Meek at a glance

More founders in Cambridge, USA (44)

Browse related founder lists (4)

Full founder directory · Investor directory · Company funding database · Fundraising library